Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-04 10:38 am Sale | 2025-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,655,548 7.700% | -43,277 (-2.55%) | Filing History |
| 2025-08-14 4:26 pm Sale | 2025-06-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 699,486 3.200% | -741,763 (-51.47%) | Filing History |
| 2025-08-05 11:22 am Purchase | 2025-06-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,698,825 8.900% | 251,275 (+17.36%) | Filing History |
| 2025-07-25 5:00 pm Purchase | 2025-07-18 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | RA Capital Management, L.P. | 2,122,000 9.900% | 2,122,000 (New Position) | Filing History |
| 2025-05-15 4:30 pm Unchanged | 2025-03-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 1,441,249 7.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 1,441,249 5.600% | -125,420 (-8.01%) | Filing History |
| 2025-02-14 10:50 am Sale | 2024-12-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | SECTORAL ASSET MANAGEMENT INC | 950,786 4.990% | -100 (-0.01%) | Filing History |
| 2024-11-14 4:38 pm Purchase | 2024-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | SECTORAL ASSET MANAGEMENT INC | 950,886 5.000% | 950,886 (New Position) | Filing History |
| 2024-10-31 12:46 pm Purchase | 2024-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,447,550 7.600% | 1,447,550 (New Position) | Filing History |
| 2024-04-15 4:38 pm Purchase | 2024-04-05 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | SUVRETTA CAPITAL MANAGEMENT LLC | 1,720,000 9.300% | 1,720,000 (New Position) | Filing History |
| 2024-04-15 4:20 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 1,566,669 8.500% | 1,566,669 (New Position) | Filing History |
| 2024-04-10 5:12 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | JOHNSON & JOHNSON JNJ | 1,979,173 10.700% | 1,979,173 (New Position) | Filing History |